Comerica Bank’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-24
Closed -$240 3744
2024
Q2
$240 Sell
24
-4
-14% -$44 ﹤0.01% 3658
2024
Q1
$340 Hold
28
﹤0.01% 3696
2023
Q4
$401 Hold
28
﹤0.01% 3680
2023
Q3
$218 Buy
+28
New +$305 ﹤0.01% 3755
2022
Q4
$193K Sell
10,355
-3,535
-25% -$61.1K ﹤0.01% 2068
2022
Q3
$212K Sell
13,890
-1,460
-10% -$28.9K ﹤0.01% 2041
2022
Q2
$459K Buy
15,350
+660
+4% +$19.6K ﹤0.01% 1867
2022
Q1
$564K Sell
14,690
-450
-3% -$19.9K ﹤0.01% 1820
2021
Q4
$638K Buy
+15,140
New +$1.15M ﹤0.01% 1771

Other funds holding OPRX

Comerica Bank's OPRX Position: Q3 2024 in Review

Comerica Bank sold out of OptimizeRx (OPRX) in Q3 2024, closing a stake of 24 shares — an estimated $240 sold.

Comerica Bank first reported a position in OPRX in Q4 2021 and held it in 9 quarters. The position peaked at $638K in Q4 2021. 85 funds tracked by Wall St. Rank hold OPRX as of Q3 2024.

  • Comerica Bank reported no remaining OptimizeRx position as of Q3 2024 after selling out during the quarter.
  • Comerica Bank sold 24 OptimizeRx shares in Q3 2024, an estimated $240.
  • Comerica Bank first reported a position in OptimizeRx in Q4 2021 and held it in 9 quarters.
  • Comerica Bank's OptimizeRx position peaked at $638K in Q4 2021.
  • 85 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2024.

Based on Comerica Bank's 13F filing for Q3 2024, filed 14 Nov 2024.